Recurrent ovarian cancer: Treatment and clinical trials July 26, 2018 Overview Show transcript Overview There are many options available to treat recurrent ovarian cancer, even if it has recurred more than once. Recurrence is common in patients with ovarian cancer. William A. Cliby, M.D., and Carrie L. Langstraat, M.D., gynecological oncologists at Mayo Clinic in Rochester, Minnesota, discuss treatment options, including: Standard-of-care chemotherapy Surgery Surgery with chemotherapy Clinical trials These options can provide meaningful benefit to patients and extend life with minimal side effects. Drs. Cliby and Langstraat also explain the types, benefits and phases of clinical trials. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleMayo Clinic investigators discover new clues to early ovarian cancer detection and treatment response predictionArticleChallenging search for ovarian cancer early detection assay appears hopefulArticleFluorescence-guided surgical advancements for patients with ovarian cancer VID-20480175 Medical Professionals Recurrent ovarian cancer: Treatment and clinical trials